Blar i HVL Open på forfatter "Buhl, Esben Selmer"
-
Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) – a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway
Forster, Rachel Bedenis; Strandberg, Ragnhild Bjarkøy; Tibballs, Katrina Louise Bø; Nøkleby, Kjersti; Berg, Tore Julsrud; Iversen, Tor; Hagen, Terje P.; Richardsen, Kåre Rønn; Cooper, John; Sandberg, Sverre; Løvaas, Karianne Fjeld; Nilsen, Roy Miodini; Iversen, Marjolein M.; Jenum, Anne Karen; Buhl, Esben Selmer (Peer reviewed; Journal article, 2022)Purpose The ‘Outcomes & Multi-morbidity in Type 2 Diabetes’ (OMIT) is an observational registry-based cohort of Norwegian patients with type 2 diabetes (T2D) established to study high-risk groups often omitted from randomised ... -
How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway
Igland, Jannicke; Forster, Rachel Bedenis; Jenum, Anne Karen; Strandberg, Ragnhild Bjarkøy; Berg, Tore Julsrud; Røssberg, Jan Ivar; Iversen, Marjolein M.; Buhl, Esben Selmer (Peer reviewed; Journal article, 2024)Objective The prescription-based Rx-risk index has previously been developed to measure multimorbidity. We aimed to adapt and evaluate the validity of the Rx-risk index in prediction of mortality among persons with type 2 ...